AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 33 cases where AXON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXON's RSI Oscillator exited the oversold zone, 19 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on AXON as a result. In 57 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for AXON just turned positive on October 06, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in 28 of 37 cases over the following month. The odds of a continued upward trend are 76%.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 57 cases where AXON's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.458) is normal, around the industry mean (5.045). AXON has a moderately high P/E Ratio (154.883) as compared to the industry average of (17.993). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
SWBI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend. In 35 of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where SWBI advanced for three days, in 177 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 98 of 162 cases where SWBI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The 10-day RSI Indicator for SWBI moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 19 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SWBI as a result. In 62 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for SWBI turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 40 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SWBI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
SWBI broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.721) is normal, around the industry mean (5.045). P/E Ratio (25.607) is within average values for comparable stocks, (17.993). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (3.110). Dividend Yield (0.036) settles around the average of (0.058) among similar stocks. P/S Ratio (1.071) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. SWBI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SWBI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
AXON | SWBI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 46 Fair valued | |
PROFIT vs RISK RATING 1..100 | 68 | 100 | |
SMR RATING 1..100 | 81 | 80 | |
PRICE GROWTH RATING 1..100 | 63 | 57 | |
P/E GROWTH RATING 1..100 | 50 | 78 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SWBI's Valuation (46) in the null industry is somewhat better than the same rating for AXON (93) in the Biotechnology industry. This means that SWBI’s stock grew somewhat faster than AXON’s over the last 12 months.
AXON's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as SWBI (100) in the null industry. This means that AXON’s stock grew similarly to SWBI’s over the last 12 months.
SWBI's SMR Rating (80) in the null industry is in the same range as AXON (81) in the Biotechnology industry. This means that SWBI’s stock grew similarly to AXON’s over the last 12 months.
SWBI's Price Growth Rating (57) in the null industry is in the same range as AXON (63) in the Biotechnology industry. This means that SWBI’s stock grew similarly to AXON’s over the last 12 months.
AXON's P/E Growth Rating (50) in the Biotechnology industry is in the same range as SWBI (78) in the null industry. This means that AXON’s stock grew similarly to SWBI’s over the last 12 months.
| AXON | SWBI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 70% | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 63% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 63% |
| Advances ODDS (%) | 10 days ago 74% | 9 days ago 64% |
| Declines ODDS (%) | 3 days ago 70% | 7 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 75% | 2 days ago 60% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 0 FA rating(s) are green while SWBI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 5 TA indicator(s) are bullish while SWBI’s TA Score has 4 bullish TA indicator(s).
AXON (@Aerospace & Defense) experienced а +0.24% price change this week, while SWBI (@Aerospace & Defense) price change was +4.32% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was -12.53%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -24.23%.
AXON is expected to report earnings on Mar 02, 2027.
SWBI is expected to report earnings on Dec 03, 2026.
Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
A.I.dvisor indicates that over the last year, SWBI has been loosely correlated with RGR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SWBI jumps, then RGR could also see price increases.
| Ticker / NAME | Correlation To SWBI | 1D Price Change % | ||
|---|---|---|---|---|
| SWBI | 100% | +10.02% | ||
| RGR - SWBI | 60% Loosely correlated | +10.62% | ||
| NPK - SWBI | 23% Poorly correlated | -1.38% | ||
| AVAV - SWBI | 22% Poorly correlated | -8.34% | ||
| AXON - SWBI | 22% Poorly correlated | +1.83% | ||
| VSEC - SWBI | 22% Poorly correlated | +0.61% | ||
More | ||||